Replies to post #184049 on Innovation Pharmaceuticals Inc (IPIX)

[Amatuer17]

Thanks for good article

Not sure K is relevant here as it has not shown the kind of dramatic efficacy the other drug has shown.

Also the entire P1 went into oblivion and they have to go for a targeted trial.

[frrol]

I should add that Kevetrin's small, short PoC Phase 2a is clearly BP bait, pure and simple. (I don't mean this to belittle its utility for clinical development at all.) The company transparently expects it, if successful, to directly result in a deal for Kevetrin.